Výsledky vyhledávání

Akademický článek

The Impact of IgG administration on the cellular immunity status in the patients with multidrug-resistant tuberculosis/HIV with CD4 + lymphocyte cells below 50 cells/ μl

Autor: Nina Matsegora, Antonina Kaprosh, Petro Antonenko

Publikováno v: International Journal of Mycobacteriology, Vol 10, Iss 2, Pp 122-128 (2021)

Background: Treatment of the patients with multidrug-resistant tuberculosis (MDR-TB)/HIV coinfection in a state of severely suppressed immune system remains unsatisfactory. Methods: The study involved 52 HIV-positive patients with MDR-TB and CD4+ lym

Externí odkaz: https://doaj.org/article/98b2d24b9f3345c68467bd76a2ad32cb

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Dynamics of hematological parameters in patients with HRTB/HIV with levels of CD4+lymphocytes 200-50 cells/μl in imunoglobulin therapy application

Autor: N. A. Matsehora, A. V. Kaprosh

Publikováno v: Journal of Education, Health and Sport, Vol 9, Iss 1, Pp 365-374 (2019)

Introduction. According to the World Health Organization (WHO), in 2017 about 10 million people became ill with TB in the world. Also, WHO reports that Ukraine belongs to countries where the number of patients with chemo-resistant tuberculosis (HRTB)

Externí odkaz: https://doaj.org/article/2c3e97f6006a4e20828afec517070a01

Zobrazit plný text záznamu

The restorative effect of immunoglobulin G on indicators of cellular immunity in patients with co-infection drug-resistant tuberculosis/HIV with a CD4 lymphocyte cоunt from 200 to 50 cells/μL

Autor: N.A. Matsegora, A.V. Kaprosh

Publikováno v: Tuberculosis, Lung Diseases, HIV Infection. :16-22

Objective — to study the restorative effect of immunoglobulin G (IgG) in patients on indicators of cellular immunity in patients with drug-resistant tuberculosis (DR-TB)/HIV co-infection at the level of CD4+ lymphocytes from 200 to 50 cells/μL. Ma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1bad488b654614453a6e2b4ee47f58a1
https://doi.org/10.30978/tb2023-1-16

Zobrazit plný text záznamu

Current state of developments and research of new candidate vaccines against tuberculosis (literature review)

Autor: N.А. Matsegora, A.V. Kaprosh

Publikováno v: Tuberculosis, Lung Diseases, HIV Infection. :48-57

147 literature sources on Tuberculosis vaccine, Vaccine prevention of tuberculosis were considered, 33 of them were studied in detail.According to the WHO report, 14 candidates for the TB vaccine are in clinical trials, including the AEC/BC02, Ad5 Ag

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::582f5fcbef329a2a4ed6531832c48a15
https://doi.org/10.30978/tb-2022-2-48

Zobrazit plný text záznamu

The effectiveness of immunoglobulin G application in patients with drug-resistant tuberculosis/HIV with CD4+ lymphocytes from 200 to 50 cells/µl according to biochemical data

Autor: A.V. Kaprosh, N.А. Matsegora

Publikováno v: Tuberculosis, Lung Diseases, HIV Infection. :43-50

Objective — to study the effectiveness of immunoglobulin therapy in patients with co-infection of drug-resistant tuberculosis (DR-TB)/HIV at the level of CD4+ lymphocytes from 200 to 50 cells/μl, based on a study of the dynamics of biochemical par

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d7bc32741861cb658dda793040adc933
https://doi.org/10.30978/tb2021-3-43

Zobrazit plný text záznamu

Clinical case of immunoglobulin G application with сhemo-resistant tuberculosis in combination with HIV-infection with severe immunosuppression

Autor: N.А. Matsegora, A.V. Kaprosh

Publikováno v: Tuberculosis, Lung Diseases, HIV Infection. :46-51

Chemo-resistant tuberculosis in combination with HIV infection is one of the most difficult problems of modern phthisiology. Of particular interest is the contingent of patients with MDR TB/HIV with a level of CD 4 in blood plasma below 50 cells/µl,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7e40ecdd7d94f77b622aaa860546297d
https://doi.org/10.30978/tb2019-1-46

Zobrazit plný text záznamu

Dynamics of hematological parameters in patients with HRTB/HIV with levels of CD4+lymphocytes 200-50 cells/μl in imunoglobulin therapy application

Autor: Matsehora, N. A., Kaprosh, A. V.

Publikováno v: Journal of Education, Health and Sport, Vol 9, Iss 1, Pp 365-374 (2019)

Matsehora N. A., Kaprosh A. V. Dynamics of hematological parameters in patients with HRTB/HIV with levels of CD4+lymphocytes 200-50 cells/μl in imunoglobulin therapy application. Journal of Education, Health and Sport. 2019;9(1):365-374. eISNN 2391-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f54de131b67f09a3647d201b7ca78c5
http://www.ojs.ukw.edu.pl/index.php/johs/article/view/6602

Zobrazit plný text záznamu

Biochemical value dynamics in patients with multidrug-resistant tuberculosis/hiv with CD4+ lymphocyte cells below 50 cells/μCL and its variability in the application of adjuvant immunoglobulin therapy

Autor: Petro B. Antonenko, Antonina V Kaprosh, Nina A Matsegora

Publikováno v: International journal of mycobacteriology. 8(4)

Treatment of the patients with multidrug-resistant tuberculosis (MDR-TB)/HIV coinfection in a state of severely suppressed immune system remains under efficient.The aim of this study was to assess the effectiveness of adjuvant immunoglobulin therapy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17654345e7400f3b10f2ecbdaed4254d
https://pubmed.ncbi.nlm.nih.gov/31793509

Zobrazit plný text záznamu

Клинический пример применения иммуноглобулина G при химиорезистентном туберкулезе в сочетании с ВИЧ-инфекцией в состоянии тяжелой иммуносупрессии

Autor: Matsegora, N.А., Kaprosh, A.V.

Publikováno v: Tuberculosis, Lung Diseases, HIV Infection; № 1 (2019); 46-51
Туберкулез, легочные болезни, ВИЧ-инфекция; № 1 (2019); 46-51
Туберкульоз, легеневі хвороби, ВІЛ-інфекція; № 1 (2019); 46-51

Хіміорезистентний туберкульоз (ХРТБ) у поєднанні з ВІЛ-інфекцією є однією з найскладніших проблем фтизіатрії. Особливу зацікавленість

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=scientific_p::34a33a7d8ae2d08bb1f6aafc8706a70e
http://tubvil.com.ua/article/view/161550

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání